Evidence map›Paper›PMID 25827227›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

A comprehensive method for detecting ubiquitinated substrates using TR-TUBE.

Yukiko Yoshida, Yasushi Saeki, Arisa Murakami, Junko Kawawaki, Hikaru Tsuchiya, Hidehito Yoshihara, Mayumi Shindo, Keiji Tanaka

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 117 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yukiko YoshidaProtein Metabolism Project, yoshida-yk@igakuken.or.jp tanaka-kj@igakuken.or.jp.
Yasushi SaekiLaboratory of Protein Metabolism, and.
Arisa MurakamiProtein Metabolism Project, Laboratory of Protein Metabolism, and.
Junko KawawakiProtein Metabolism Project.
Hikaru TsuchiyaLaboratory of Protein Metabolism, and.
Hidehito YoshiharaLaboratory of Protein Metabolism, and.
Mayumi ShindoCenter for Basic Technology Research, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan.
Keiji TanakaLaboratory of Protein Metabolism, and yoshida-yk@igakuken.or.jp tanaka-kj@igakuken.or.jp.
Tokyo Metropolitan Institute of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of substrates for ubiquitin ligases has remained challenging, because most substrates are either immediately degraded by the proteasome or processed by deubiquitinating enzymes (DUBs) to remove polyubiquitin. Although a methodology that enables detection of ubiquitinated proteins using ubiquitin Lys-ε-Gly-Gly (diGly) remnant antibodies and MS has been developed, it is still insufficient for identification and characterization of the ubiquitin-modified proteome in cells overexpressing a particular ubiquitin ligase. Here, we show that exogenously expressed trypsin-resistant tandem ubiquitin-binding entity(ies) (TR-TUBE) protect polyubiquitin chains on substrates from DUBs and circumvent proteasome-mediated degradation in cells. TR-TUBE effectively associated with substrates ubiquitinated by an exogenously overexpressed ubiquitin ligase, allowing detection of the specific activity of the ubiquitin ligase and isolation of its substrates. Although the diGly antibody enabled effective identification of ubiquitinated proteins in cells, overexpression of an ubiquitin ligase and treatment with a proteasome inhibitor did not increase the level of diGly peptides specific for the ligase relative to the background level of diGly peptides, probably due to deubiquitination. By contrast, in TR-TUBE-expressing cells, the level of substrate-derived diGly peptides produced by the overexpressed ubiquitin ligase was significantly elevated. We developed a method for identifying the substrates of specific ubiquitin ligases using two enrichment strategies, TR-TUBE and diGly remnant antibodies, coupled with MS. Using this method, we identified target substrates of FBXO21, an uncharacterized F-box protein.

Indexed as

UbiquitinationAmino Acid SequenceAntibodiesBase SequenceF-Box ProteinsGlycineHEK293 CellsHumansImmunoblottingImmunoprecipitationLysineMolecular Sequence DataOligopeptidesProtein BindingProteomeProteomicsAntibodiesF-Box ProteinsGlycineLysineOligopeptidesProteomeTrypsinUbiquitinUbiquitinated ProteinsUbiquitin-Protein Ligasesubiquitinationubiquitin-binding proteinubiquitin ligase

Identifiers

PMID25827227
PMCPMC4403176
OpenAlexW2045012604

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.